🇺🇸 FDA
Patent

US 10626146

α4β7 thioether peptide dimer antagonists

granted A61KA61K38/00A61K38/12

Quick answer

US patent 10626146 (α4β7 thioether peptide dimer antagonists) held by Protagonist Therapeutics, Inc. expires Mon Apr 16 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Protagonist Therapeutics, Inc.
Grant date
Tue Apr 21 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 16 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
22
CPC classes
A61K, A61K38/00, A61K38/12, A61K47/54, A61K47/545